Author
Rockefeller UniversityORCID 0000-0001-5177-2068Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Trinity M. Zang, Viren A. Baharani, Miranda Aldis…·Paul D. Bieniasz
This paper designs an overlapping variant immunogen pool that elicits broad neutralization against SARS-CoV-2 variants and a chimeric SARS-CoV-1 virus.
Tomás Cervantes Rincón, Tereza Frčková, Zaria I. Contejean…·Davide F. Robbiani
The paper identifies two human monoclonal antibodies that neutralize West Nile virus and related orthoflaviruses, offering potential for antibody-based interventions.
Mariana Nogueira Batista, Juliano Bordignon, Ana Luiza Pamplona Mosimann…·Charles M. Rice
This study develops an immunocompetent mouse model of virus-induced liver fibrosis and hepatocellular carcinoma using Norway rat hepacivirus.
Samantha G. Muccilli, Benjamin H. Schwarz, Byron Shue…·Sonja M. Best
This study identifies mitochondrial hyperactivity and reactive oxygen species as critical drivers of innate immunity to the YFV-17D vaccine, enhancing IFN response and vaccine effectiveness.
Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast…·Charles M. Rice
The paper identifies PLSCR1 as a host factor restricting SARS-CoV-2 entry, which recent variants have evolved to bypass, through a CRISPR screen and integration of genetic studies.
Hans-Heinrich Hoffmann, William M. Schneider, Kathryn Rozen-Gagnon…·Charles M. Rice
The paper identifies TMEM41B as a host factor required for flavivirus infection and shows SNPs in TMEM41B reduce infection in East Asian populations.